NICHOLLE ELIZABETH SHANNON CRNP
Prescription History 1164094967
Nurse Practitioner in Center Valley, PA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for NICHOLLE ELIZABETH SHANNON CRNP, an active Nurse Practitioner specialist practicing in Center Valley, PA. Our medical registry currently tracks 42 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,871 documented patient claims. Among these therapy options, the most frequently utilized medication is Ozempic, which accounts for 179 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other PA PrescribersVs. PA Avg |
|---|---|---|---|
| OzempicSemaglutide | 179 | $1,459.11 | ▲ More than typical |
About Ozempic: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment. In 2023, this provider wrote 179 Medicare prescriptions for Ozempic, about 4.1 times the volume of the typical Pennsylvania prescriber of this medication (44). Medicare paid an average of $1,459.11 per fill, versus $1,290.38 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 266.1 30-Day Fills standardized to 30-day supplies 7,745 Days of Medication total across all patients in 2023 | |||
| Novolog FlexpenInsulin Aspart | 150 | $1,005.39 | ▲ More than typical |
About Novolog Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2023, this provider wrote 150 Medicare prescriptions for Novolog Flexpen, about 4.1 times the volume of the typical Pennsylvania prescriber of this medication (37). Medicare paid an average of $1,005.39 per fill, versus $898.23 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 288.7 30-Day Fills standardized to 30-day supplies 8,300 Days of Medication total across all patients in 2023 | |||
| Levothyroxine Sodium | 134 | $15.46▼ below PA avg | ≈ Typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2023, this provider wrote 134 Medicare prescriptions for Levothyroxine Sodium, about 78% of the volume of the typical Pennsylvania prescriber of this medication (171). Medicare paid an average of $15.46 per fill, versus $16.47 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 322 30-Day Fills standardized to 30-day supplies 9,626 Days of Medication total across all patients in 2023 | |||
| Metformin Hcl | 125 | $10.74 | ≈ Typical |
About Metformin Hcl: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2023, this provider wrote 125 Medicare prescriptions for Metformin Hcl, about 1.2 times the volume of the typical Pennsylvania prescriber of this medication (106). Medicare paid an average of $10.74 per fill, versus $9.38 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 317 30-Day Fills standardized to 30-day supplies 9,486 Days of Medication total across all patients in 2023 | |||
| JardianceEmpagliflozin | 121 | $1,018.20 | ▲ More than typical |
About Jardiance: Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Empagliflozin works by increasing the removal of sodium by your kidneys. In 2023, this provider wrote 121 Medicare prescriptions for Jardiance, about 2.5 times the volume of the typical Pennsylvania prescriber of this medication (48). Medicare paid an average of $1,018.20 per fill, versus $939.26 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 206.3 30-Day Fills standardized to 30-day supplies 6,143 Days of Medication total across all patients in 2023 | |||
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 117 | $657.13 | ▲ More than typical |
About Lantus Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 117 Medicare prescriptions for Lantus Solostar, about 2.9 times the volume of the typical Pennsylvania prescriber of this medication (41). Medicare paid an average of $657.13 per fill, versus $552.83 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 273.6 30-Day Fills standardized to 30-day supplies 8,019 Days of Medication total across all patients in 2023 | |||
| TrulicityDulaglutide | 106 | $1,697.85 | ▲ More than typical |
About Trulicity: Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment. In 2023, this provider wrote 106 Medicare prescriptions for Trulicity, about 2.2 times the volume of the typical Pennsylvania prescriber of this medication (48). Medicare paid an average of $1,697.85 per fill, versus $1,235.23 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 179.6 30-Day Fills standardized to 30-day supplies 5,269 Days of Medication total across all patients in 2023 | |||
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 84 | $111.27 | ▲ More than typical |
In 2023, this provider wrote 84 Medicare prescriptions for Nano 2nd Gen Pen Needle, about 2.9 times the volume of the typical Pennsylvania prescriber of this medication (29). Medicare paid an average of $111.27 per fill, versus $93.10 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 184.7 30-Day Fills standardized to 30-day supplies 5,421 Days of Medication total across all patients in 2023 | |||
| Tresiba Flextouch U-100Insulin Degludec | 79 | $705.81 | ▲ More than typical |
About Tresiba Flextouch U-100: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2023, this provider wrote 79 Medicare prescriptions for Tresiba Flextouch U-100, about 2.8 times the volume of the typical Pennsylvania prescriber of this medication (28). Medicare paid an average of $705.81 per fill, versus $700.28 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 159.4 30-Day Fills standardized to 30-day supplies 4,760 Days of Medication total across all patients in 2023 | |||
| Metformin Hcl ErMetformin Hcl | 75 | $22.81 | ▲ More than typical |
About Metformin Hcl Er: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2023, this provider wrote 75 Medicare prescriptions for Metformin Hcl Er, about 1.4 times the volume of the typical Pennsylvania prescriber of this medication (52). Medicare paid an average of $22.81 per fill, versus $13.63 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 205.3 30-Day Fills standardized to 30-day supplies 6,136 Days of Medication total across all patients in 2023 | |||
| Glimepiride | 62 | $9.14▼ below PA avg | ▲ More than typical |
About Glimepiride: Glimepiride is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glimepiride belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. Alkaloids derived from TYRAMINE combined with 3,4-dihydroxybenzaldehyde via a norbelladine pathway, including GALANTAMINE, lycorine and crinine. They are found in the AMARYLLIDACEAE plant family. In 2023, this provider wrote 62 Medicare prescriptions for Glimepiride, about 1.4 times the volume of the typical Pennsylvania prescriber of this medication (44). Medicare paid an average of $9.14 per fill, versus $15.24 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 155.5 30-Day Fills standardized to 30-day supplies 4,665 Days of Medication total across all patients in 2023 | |||
| Humalog Kwikpen U-100Insulin Lispro | 43 | $1,311.61 | ▲ More than typical |
About Humalog Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2023, this provider wrote 43 Medicare prescriptions for Humalog Kwikpen U-100, about 1.4 times the volume of the typical Pennsylvania prescriber of this medication (31). Medicare paid an average of $1,311.61 per fill, versus $843.87 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 103.1 30-Day Fills standardized to 30-day supplies 3,070 Days of Medication total across all patients in 2023 | |||
| SynthroidLevothyroxine Sodium | 41 | $69.52▼ below PA avg | ≈ Typical |
About Synthroid: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2023, this provider wrote 41 Medicare prescriptions for Synthroid, about the same volume as the typical Pennsylvania prescriber of this medication (44). Medicare paid an average of $69.52 per fill, versus $70.80 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 85.5 30-Day Fills standardized to 30-day supplies 2,523 Days of Medication total across all patients in 2023 | |||
| Atorvastatin Calcium | 40 | $21.10 | ▼ Less than typical |
About Atorvastatin Calcium: Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors. In 2023, this provider wrote 40 Medicare prescriptions for Atorvastatin Calcium, about 20% of the volume of the typical Pennsylvania prescriber of this medication (204). Medicare paid an average of $21.10 per fill, versus $14.17 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 112 30-Day Fills standardized to 30-day supplies 3,358 Days of Medication total across all patients in 2023 | |||
| Repaglinide | 39 | $40.94▼ below PA avg | ▲ More than typical |
About Repaglinide: Repaglinide is used alone or with other medications to control high blood sugar along with a proper diet and exercise program. Show more ▾ It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. It works by stimulating the body to produce more insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. In 2023, this provider wrote 39 Medicare prescriptions for Repaglinide, about 1.3 times the volume of the typical Pennsylvania prescriber of this medication (30). Medicare paid an average of $40.94 per fill, versus $64.29 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 77.2 30-Day Fills standardized to 30-day supplies 2,296 Days of Medication total across all patients in 2023 | |||
| Tresiba Flextouch U-200Insulin Degludec | 36 | $1,082.70▼ below PA avg | ≈ Typical |
About Tresiba Flextouch U-200: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2023, this provider wrote 36 Medicare prescriptions for Tresiba Flextouch U-200, about 1.2 times the volume of the typical Pennsylvania prescriber of this medication (29). Medicare paid an average of $1,082.70 per fill, versus $1,171.65 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 74 30-Day Fills standardized to 30-day supplies 2,201 Days of Medication total across all patients in 2023 | |||
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 28 | $1,058.71 | ≈ Typical |
About Toujeo Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 28 Medicare prescriptions for Toujeo Solostar, about 1.2 times the volume of the typical Pennsylvania prescriber of this medication (24). Medicare paid an average of $1,058.71 per fill, versus $699.22 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 62.3 30-Day Fills standardized to 30-day supplies 1,861 Days of Medication total across all patients in 2023 | |||
| Methimazole | 27 | $11.29▼ below PA avg | ≈ Typical |
About Methimazole: Methimazole is used to treat overactive thyroid (hyperthyroidism). Show more ▾ It works by stopping the thyroid gland from making too much thyroid hormone. A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme. In 2023, this provider wrote 27 Medicare prescriptions for Methimazole, about 82% of the volume of the typical Pennsylvania prescriber of this medication (33). Medicare paid an average of $11.29 per fill, versus $12.03 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 57.8 30-Day Fills standardized to 30-day supplies 1,734 Days of Medication total across all patients in 2023 | |||
| Losartan Potassium | 23 | $21.36 | ▼ Less than typical |
About Losartan Potassium: Losartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. Show more ▾ It is also used to lower the risk of strokes in patients with high blood pressure and an enlarged heart. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Losartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily. An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II. In 2023, this provider wrote 23 Medicare prescriptions for Losartan Potassium, about a quarter of the volume of the typical Pennsylvania prescriber of this medication (105). Medicare paid an average of $21.36 per fill, versus $13.26 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 49 30-Day Fills standardized to 30-day supplies 1,470 Days of Medication total across all patients in 2023 | |||
| Rosuvastatin Calcium | 23 | $18.11▼ below PA avg | ▼ Less than typical |
About Rosuvastatin Calcium: Rosuvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks. In addition to eating a proper diet (such as a low cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Talk with your doctor for more details. A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES. In 2023, this provider wrote 23 Medicare prescriptions for Rosuvastatin Calcium, about a quarter of the volume of the typical Pennsylvania prescriber of this medication (96). Medicare paid an average of $18.11 per fill, versus $30.45 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 60.4 30-Day Fills standardized to 30-day supplies 1,812 Days of Medication total across all patients in 2023 | |||
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 23 | $382.27▼ below PA avg | ≈ Typical |
About Basaglar Kwikpen U-100: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 23 Medicare prescriptions for Basaglar Kwikpen U-100, about 77% of the volume of the typical Pennsylvania prescriber of this medication (30). Medicare paid an average of $382.27 per fill, versus $382.38 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 45.7 30-Day Fills standardized to 30-day supplies 1,370 Days of Medication total across all patients in 2023 | |||
| Levemir FlexpenInsulin Detemir | 20 | $672.56 | – No State Data |
About Levemir Flexpen: Insulin detemir is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin detemir is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin detemir may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs (such as metformin, exenatide). A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS. In 2023, this provider wrote 20 Medicare prescriptions for Levemir Flexpen. Medicare paid an average of $672.56 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $672.56 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 57.5 30-Day Fills standardized to 30-day supplies 1,706 Days of Medication total across all patients in 2023 | |||
| Insulin Aspart FlexpenInsulin Aspart | 20 | $423.76 | ≈ Typical |
About Insulin Aspart Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2023, this provider wrote 20 Medicare prescriptions for Insulin Aspart Flexpen, about the same volume as the typical Pennsylvania prescriber of this medication (20). Medicare paid an average of $423.76 per fill, versus $264.83 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 37 30-Day Fills standardized to 30-day supplies 1,110 Days of Medication total across all patients in 2023 | |||
| FarxigaDapagliflozin Propanediol | 20 | $1,471.28 | ▼ Less than typical |
About Farxiga: Dapagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used in people with type 2 diabetes and heart disease to lower the risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sugar by your kidneys. Dapagliflozin is also used to treat kidney disease and heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sodium by your kidneys. In 2023, this provider wrote 20 Medicare prescriptions for Farxiga, about 61% of the volume of the typical Pennsylvania prescriber of this medication (33). Medicare paid an average of $1,471.28 per fill, versus $886.40 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 52 30-Day Fills standardized to 30-day supplies 1,560 Days of Medication total across all patients in 2023 | |||
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 19 | $1,011.52▼ below PA avg | ≈ Typical |
About Novolog Mix 70-30 Flexpen: Insulin aspart protamine/insulin aspart is used along with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ This product is a combination of two man-made insulins: intermediate-acting insulin aspart protamine and rapid-acting insulin aspart. This combination starts working faster and lasts for a longer time than regular insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. It replaces the insulin that your body no longer produces, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. In 2023, this provider wrote 19 Medicare prescriptions for Novolog Mix 70-30 Flexpen, about 83% of the volume of the typical Pennsylvania prescriber of this medication (23). Medicare paid an average of $1,011.52 per fill, versus $1,164.48 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 21.2 30-Day Fills standardized to 30-day supplies 635 Days of Medication total across all patients in 2023 | |||
| Insulin SyringeSyringe And Needle,insulin,1ml | 17 | $55.77 | ≈ Typical |
In 2023, this provider wrote 17 Medicare prescriptions for Insulin Syringe, about 1.2 times the volume of the typical Pennsylvania prescriber of this medication (14). Medicare paid an average of $55.77 per fill, versus $46.16 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19.8 30-Day Fills standardized to 30-day supplies 534 Days of Medication total across all patients in 2023 | |||
| Comfort Ez Pen NeedlePen Needle, Diabetic | 17 | $111.33▼ below PA avg | ▼ Less than typical |
In 2023, this provider wrote 17 Medicare prescriptions for Comfort Ez Pen Needle, about 74% of the volume of the typical Pennsylvania prescriber of this medication (23). Medicare paid an average of $111.33 per fill, versus $120.08 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 21 30-Day Fills standardized to 30-day supplies 585 Days of Medication total across all patients in 2023 | |||
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 17 | $92.09 | ≈ Typical |
In 2023, this provider wrote 17 Medicare prescriptions for Ultra-Fine Mini Pen Needle, about 81% of the volume of the typical Pennsylvania prescriber of this medication (21). Medicare paid an average of $92.09 per fill, versus $81.63 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 37 30-Day Fills standardized to 30-day supplies 1,080 Days of Medication total across all patients in 2023 | |||
| Xultophy 100-3.6Insulin Degludec/Liraglutide | 16 | $1,577.72 | ▼ Less than typical |
About Xultophy 100-3.6: This medication is a combination of insulin degludec and liraglutide and is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Liraglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high sugar levels (such as after a meal) and decreasing the amount of sugar your liver makes. In 2023, this provider wrote 16 Medicare prescriptions for Xultophy 100-3.6, about 73% of the volume of the typical Pennsylvania prescriber of this medication (22). Medicare paid an average of $1,577.72 per fill, versus $1,436.36 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28.4 30-Day Fills standardized to 30-day supplies 853 Days of Medication total across all patients in 2023 | |||
| Omnipod 5 G6 Pods (Gen 5)Insulin Pump Cart,automated,bt | 16 | $1,062.31 | ≈ Typical |
In 2023, this provider wrote 16 Medicare prescriptions for Omnipod 5 G6 Pods (Gen 5), about the same volume as the typical Pennsylvania prescriber of this medication (17). Medicare paid an average of $1,062.31 per fill, versus $929.63 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24 30-Day Fills standardized to 30-day supplies 720 Days of Medication total across all patients in 2023 | |||
| Lisinopril | 15 | $8.69 | ▼ Less than typical |
About Lisinopril: Lisinopril is used to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat heart failure and to improve survival after a heart attack. Lisinopril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily. One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure. In 2023, this provider wrote 15 Medicare prescriptions for Lisinopril, about 11% of the volume of the typical Pennsylvania prescriber of this medication (135). Medicare paid an average of $8.69 per fill, versus $8.19 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 33.5 30-Day Fills standardized to 30-day supplies 995 Days of Medication total across all patients in 2023 | |||
| JanuviaSitagliptin Phosphate | 15 | $1,199.07 | ▼ Less than typical |
About Januvia: Sitagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Sitagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES. In 2023, this provider wrote 15 Medicare prescriptions for Januvia, about half the volume of the typical Pennsylvania prescriber of this medication (34). Medicare paid an average of $1,199.07 per fill, versus $897.35 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 31 30-Day Fills standardized to 30-day supplies 920 Days of Medication total across all patients in 2023 | |||
| RybelsusSemaglutide | 14 | $2,672.06 | ▼ Less than typical |
About Rybelsus: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment. In 2023, this provider wrote 14 Medicare prescriptions for Rybelsus, about 61% of the volume of the typical Pennsylvania prescriber of this medication (23). Medicare paid an average of $2,672.06 per fill, versus $1,225.67 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 38 30-Day Fills standardized to 30-day supplies 1,140 Days of Medication total across all patients in 2023 | |||
| Droplet Pen NeedlePen Needle, Diabetic | 14 | $81.15 | ▼ Less than typical |
In 2023, this provider wrote 14 Medicare prescriptions for Droplet Pen Needle, about 74% of the volume of the typical Pennsylvania prescriber of this medication (19). Medicare paid an average of $81.15 per fill, versus $68.76 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30.7 30-Day Fills standardized to 30-day supplies 905 Days of Medication total across all patients in 2023 | |||
| Bd Insulin Syringe Ultra-FineSyringe-Needle,insulin,0.5 Ml | 14 | $34.16 | ≈ Typical |
In 2023, this provider wrote 14 Medicare prescriptions for Bd Insulin Syringe Ultra-Fine, about the same volume as the typical Pennsylvania prescriber of this medication (13). Medicare paid an average of $34.16 per fill, versus $25.39 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16 30-Day Fills standardized to 30-day supplies 415 Days of Medication total across all patients in 2023 | |||
| MounjaroTirzepatide | 13 | $1,517.21 | ≈ Typical |
About Mounjaro: Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. It lowers blood sugar by causing the release of your body's natural insulin and decreasing the amount of sugar your liver makes. A glucose-dependent insulinotropic polypeptide (GIP) receptor and Glucose-like peptide-1 (GLP-1) receptor agonist to enhance glycemic control in adults with TYPE 2 DIABETES MELLITUS. In 2023, this provider wrote 13 Medicare prescriptions for Mounjaro, about 76% of the volume of the typical Pennsylvania prescriber of this medication (17). Medicare paid an average of $1,517.21 per fill, versus $1,200.61 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17.5 30-Day Fills standardized to 30-day supplies 508 Days of Medication total across all patients in 2023 | |||
| Simvastatin | 12 | $16.67 | ▼ Less than typical |
About Simvastatin: Simvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. A derivative of LOVASTATIN and potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It may also interfere with steroid hormone production. Due to the induction of hepatic LDL RECEPTORS, it increases breakdown of LDL CHOLESTEROL. In 2023, this provider wrote 12 Medicare prescriptions for Simvastatin, about 13% of the volume of the typical Pennsylvania prescriber of this medication (95). Medicare paid an average of $16.67 per fill, versus $10.55 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36 30-Day Fills standardized to 30-day supplies 1,080 Days of Medication total across all patients in 2023 | |||
| LantusInsulin Glargine,hum.Rec.Anlog | 12 | $1,019.50 | ▼ Less than typical |
About Lantus: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 12 Medicare prescriptions for Lantus, about half the volume of the typical Pennsylvania prescriber of this medication (26). Medicare paid an average of $1,019.50 per fill, versus $477.90 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24.2 30-Day Fills standardized to 30-day supplies 722 Days of Medication total across all patients in 2023 | |||
| Ultra-Fine Nano Pen NeedlePen Needle, Diabetic | 12 | $148.36 | ▼ Less than typical |
In 2023, this provider wrote 12 Medicare prescriptions for Ultra-Fine Nano Pen Needle, about half the volume of the typical Pennsylvania prescriber of this medication (23). Medicare paid an average of $148.36 per fill, versus $80.32 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36.5 30-Day Fills standardized to 30-day supplies 1,095 Days of Medication total across all patients in 2023 | |||
| Humulin R U-500 KwikpenInsulin Regular, Human | 11 | $1,555.92▼ below PA avg | ▼ Less than typical |
About Humulin R U-500 Kwikpen: Inhaled insulin powder is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a short-acting insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This product is absorbed into the blood through your lungs. It starts working faster and lasts for a shorter time than regular insulin injected under the skin. It is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin). In 2023, this provider wrote 11 Medicare prescriptions for Humulin R U-500 Kwikpen, about half the volume of the typical Pennsylvania prescriber of this medication (26). Medicare paid an average of $1,555.92 per fill, versus $1,676.19 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 17.5 30-Day Fills standardized to 30-day supplies 497 Days of Medication total across all patients in 2023 | |||
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 11 | $139.32 | ▼ Less than typical |
In 2023, this provider wrote 11 Medicare prescriptions for Ultra-Fine Short Pen Needle, about half the volume of the typical Pennsylvania prescriber of this medication (19). Medicare paid an average of $139.32 per fill, versus $84.80 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 29 30-Day Fills standardized to 30-day supplies 870 Days of Medication total across all patients in 2023 | |||
| Alcohol SwabsAlcohol Antiseptic Pads | 11 | $7.55 | ▼ Less than typical |
In 2023, this provider wrote 11 Medicare prescriptions for Alcohol Swabs, about a third of the volume of the typical Pennsylvania prescriber of this medication (27). Medicare paid an average of $7.55 per fill, versus $5.63 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15.3 30-Day Fills standardized to 30-day supplies 449 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for NICHOLLE ELIZABETH SHANNON CRNP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Nurse Practitioner prescribing approach at this Center Valley, PA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among PA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
